Fischer Medical Ventures profit and loss

Latest FY26

Revenue: ₹309cr
EBITDA: ₹43.1cr
Net profit: ₹31.0cr
EPS: ₹0.48

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026

Expenses
	367	309
	6.3	12.3
	373	321
	106	62.2
	98.0	83.5
	−16.0	−3.2
	16.5	15.1
	8.7	5.8
	3.6	3.0
	112	108
	329	274
	50.1	43.1
	46.5	40.1
Profit
	44.1	46.6
	44.1	46.6
	14.6	16.6
	−0.4	−1.3
	14.2	15.3
	−0.1	−0.2
	29.8	31.0
	29.9	31.2
	0.1	0.1
	29.9	31.1
Per share
	₹2.40	₹0.48
	₹2.55	₹0.45
Other comprehensive income — detail
	0.1	0.1
	0.0	−0.1
Per share — as-filed variants
	₹2.40	₹0.48
	₹2.55	₹0.45
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	179	166
	48.7%	53.8%
Adjusted (ex-exceptional items) — derived
	44.1	46.6
	29.8	31.0
	₹2.40	₹0.48

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

FISCHER₹25.93

Fischer Medical Ventures Limited

· Pharma & Health

Annual Quarterly₹ CrorePeersTARSONS LAXMIDENTL FABTECH GKBMcap ₹1,697 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	308.6	367.1
Other Income	12.3	6.3
Total Income	320.9	373.4
Expenses
+ Cost of Materials Consumed	62.2	106.2
+ Purchases of Stock-in-Trade	83.5	98.0
+ Changes in Inventories	-3.2	-16.0
+ Employee Benefit Expense	15.1	16.5
+ Finance Costs	5.8	8.7
+ Depreciation & Amortisation	3.0	3.6
+ Other Expenses	107.8	112.3
Total Expenses	274.3	329.3
EBITDA	43.1	50.1
EBIT	40.1	46.5
Profit
PBT before Exceptional Items	46.6	44.1
Pretax Income	46.6	44.1
+ Current Tax	16.6	14.6
+ Deferred Tax	-1.3	-0.4
Tax Expense	15.3	14.2
+ Share of Associates & JVs	-0.2	-0.1
Net Income	31.0	29.8
+ Net Income — Continuing Ops	31.2	29.9
+ Other Comprehensive Income	0.1	0.1
Total Comprehensive Income	31.1	29.9
Per Share
Basic EPS	0.48	2.40
Diluted EPS	0.45	2.55
Other Comprehensive Income — detail
+ Other Comprehensive Income	0.1	0.1
+ Tax on Items NOT to be Reclassified	-0.1	0.0
Per Share — as-filed variants
Basic EPS — Continuing Operations	0.48	2.40
Diluted EPS — Continuing Operations	0.45	2.55
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	166.0	178.8
Gross Margin %	53.79	48.71
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	46.6	44.1
Net Income Adj (tax-effected)	31.0	29.8
EPS Adj	0.48	2.40
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	1.00	1.00
Paid Up Equity Capital	65.5	65.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.